Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres
- 1 May 1997
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 151 (1) , 57-67
- https://doi.org/10.1016/s0378-5173(97)04887-4
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- In vivo studies with antisense oligonucleotidesTrends in Pharmacological Sciences, 1997
- Anti-HIV therapy with antisense oligonucleotides and ribozymes: realistic approaches or expensive myths?Journal of Antimicrobial Chemotherapy, 1996
- The Influence of Polarized Epithelial (Caco-2) Cell Differentiation on the Cellular Binding of Phosphodiester and Phosphorothioate OligonucleotidesAntisense and Nucleic Acid Drug Development, 1996
- Interactions of Phosphodiester and Phosphorothioate Oligonucleotides with Intestinal Epithelial Caco-2 CellsPharmaceutical Research, 1996
- Synthesis of mono- and dimannoside phosphoramidite derivatives for solid-phase conjugation to oligonucleotidesTetrahedron Letters, 1995
- Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administrationBiochemical Pharmacology, 1995
- Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.Journal of Clinical Investigation, 1995
- Cellular uptake and intracellular fate of antisense oligonucleotidesTrends in Cell Biology, 1992
- Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to ratsBiomaterials, 1992
- Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and seraLife Sciences, 1991